期刊文献+

2004~2006年我院抗菌药用药分析 被引量:2

Analysis of Antibacterial Used in Xuanwu Hospital in 2004~2006
下载PDF
导出
摘要 目的:了解分析抗菌药的用药特点、发展趋势和存在问题,促进临床合理用药。方法:利用医院药库计算机网络管理系统收集我院2004年1月~2006年12月抗菌药的出库销售数据,采用医院药品DDDs排序分析原理进行分类、统计、分析。结果:抗菌药占全院药品销售总金额的比例逐年下降。三年平均比例为17.01%,低于全国医院27.97%的平均水平;喹诺酮类药物的DDDs一直处于第一位,年平均增长率14.1%;头孢菌素类稳居第二,DDDs年平均增长率13.61%。用药金额头孢菌素类远高于喹诺酮类药。结论:我院抗菌药临床使用的总体水平正朝着趋于合理的方向发展。 Objective: To investigate the use of antibacterial in our hospital in 2004 - 2006 and analyze its features and tendency so as to provide references for the rational use. Method : The stocked data of antibacterial from 2004 - 2006 were collected by the computer management system. The DDDs of antibacterial in our hospital were classified and analyzed according to the defined daily dose (DDD). Result: The ratio of the antibacterial costs in the annual drug consumption sum was decreased year by year. The average ratio was 17.01% in three years, lower than the 27.97%, which was the average of total hospitals in China. The DDDs of quinolones in our hospital had been dominating the first place in 2004 -2006, and the average increase was 14.1% in three years. The second was cephalosporins with 13.61% of its average increase,similar to quinolones, but its consumption sum was more than that of quinolanes. Conclusion: The use of antibacterial in our hospital in 2004 -2006 was rational on the whole.
作者 闻满华
出处 《药物流行病学杂志》 CAS 2008年第5期334-337,共4页 Chinese Journal of Pharmacoepidemiology
关键词 抗菌药 药物利用 合理用药 Antibacterial Drug utilization Rational drug use
  • 相关文献

参考文献7

二级参考文献22

  • 1张继春,金岩,李大魁,彭名炜.北京地区主要抗生素使用频度分析[J].中国药学杂志,1994,29(6):373-376. 被引量:34
  • 2刘屏,张志萍,陈宜鸿,孙映和,颜青,李辉.我院门诊处方中抗菌药物使用研究[J].中国药房,1995,6(2):23-24. 被引量:15
  • 3邹豪,邵元福,朱才娟,邓渝林,马玉杰,陈盛新.医院药品DDD数排序分析的原理及利用[J].中国药房,1996,7(5):215-217. 被引量:1426
  • 4Grif K, Manfred P D, Pfaller K, et al. In vitro activity of fosfomycin in combination with various antistaphyloccal substances [J]. J Antimicrob Chemother , 2001,48: 209.
  • 5Utsui Y, Ohya S, Magaribuchi T, et al. Antibacterial activity of cefmetazole alone and in combination with fosfomycin against methicillin- and cephem-resistant Staphylococcus aureus [J]. Antimicrob Agents Chemother, 1986,30(6):917.
  • 6NCCLS. Performance Standards for antimicrobial susceptibility testing [S]. 2002, vol. 22 No. 1 M100-S12 M2-A7andM7-A5.
  • 7倪语星 洪秀华.联合药物敏感试验和体外杀菌试验[A]..细菌耐药性监测与抗感染治疗[M].北京:人民军医出版社,2002-4.83.
  • 8Nabin K, Shrestha J, Tomford W. Fosfomycin: A review [J]. Infect Dis Clin Prac ,2001,10(5 ) :255.
  • 9Del V O, Trincado P, Martin M T, et al. The prevalence of methicillin-resistant Staphylococcus aureus phagotype 95in the Hospitals vall d' Hebron of Barcelona [J]. Enferm Infecc Microbiol Clin,1999,17(10):498.
  • 10Yoshida R, Kuwahara-Arai K, Baba T, et al. Physiological and molecular analysis of a mecA-negative Staphylococcus aureus clinical strain that expresses heterogeneous methicillin resistance [J]. J Antimicrob Chemoth, 2003,51:247.

共引文献1460

同被引文献8

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部